Effect of oral tofacitinib and oral methylprednisolone mini-pulse and combination of both in alopecia areata.
Phase 3
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2024/02/063353
- Lead Sponsor
- Institute of Medical Sciences BH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinically diagnosed cases of alopecia areata with severity of alopecia tool (SALT) score of 10 % or over.
2. Age: 18 to 65 years
3. Patients not taking systemic drug in last 1 month and topical treatment in last 15 days.
- All participants who give consent for the study
Exclusion Criteria
1. Patients having history or active tuberculosis.
2. Patients with Pregnancy and lactating mother.
3. Patients with uncontrolled renal, hepatic,
hematological or heart disease.
4. Patients with diabetes mellitus and hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method